Wingreens Ne Kharidi Safe Harvest! Health Food Mein Dhamaka, IPO Ki Taiyari Shuru

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorKavya Nair|Published at:
Wingreens Ne Kharidi Safe Harvest! Health Food Mein Dhamaka, IPO Ki Taiyari Shuru
Overview

Arre yaar, Wingreens World ne apna health food ka game aur bhi mazboot kar liya hai! Unhone Bengaluru ki company Safe Harvest ko khareed liya hai jo staples aur cold-pressed oils banati hai. Ye deal unke business ko ekdum naye level par le jaayegi, aur bhai, future mein IPO ka bhi plan hai!

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Wingreens Ki Nayi Chaal: Safe Harvest Ab Unka!

Wingreens World, apne health and wellness brand ko expand karne ke liye ek dum taiyaar hai. Isi plan ke tehth, unhone Safe Harvest ko share swap ke through acquire kar liya hai. Safe Harvest wale staples aur natural oils banate hain, jo ab Wingreens ke collection mein jud jayenge, jisme pehle se hi Wingreens Farms dips aur Raw Pressery juices jaise brands hain.

Paisa Kahan Se Aaya Aur Kitna?

Ye deal aise hi nahi hui, bhai. Wingreens ne Series D funding mein ₹120 Crore se zyada cash raised kiya hai, jo total ₹556 Crore ka hissa hai. Is round ko investor Ashish Kacholia ne lead kiya tha. Company ka FY26 mein revenue ₹362 Crore raha, jo FY25 ke ₹289 Crore se kaafi upar hai. Aur sabse achhi baat? FY26 mein company EBITDA level par profitable ho gayi hai, jo FY24 ke ₹65 Crore ke loss se ekdum shaandaar improvement hai. Ye sab dekh kar, company ka aim hai ki agle 2 saal mein stock market mein list ho jaye.

India Ka Health Market Aur Wingreens Ka Position

India mein health aur wellness sector bohot tezi se badh raha hai. Organic food market $7.6 Billion tak pahunch sakta hai 2030 tak, aur iski CAGR 20.8% hai. Ready-to-eat meals market bhi 2034 tak double hone ki ummeed hai. Wingreens ka FY26 revenue ₹362 Crore hai, jo badhiya hai, par Hindustan Unilever (HUL) jaisi badi companies jinka FY25 revenue ₹63,121 Crore tha, ya Marico (FY26 revenue ₹13,611 Crore) se abhi bhi kaafi kam hai. Publicly traded companies jaise HUL aur Marico ka P/E ratio 33-55 aur 59-60 ke beech chal raha hai, aur Tata Consumer Products ka around 71-80 hai. Lekin Wingreens ko mili substantial funding aur positive operating earnings (EBITDA) se lagta hai ki investors ko unke growth potential par bharosa hai.

Competition Aur Challenges?

Par bhai, sab kuch itna aasan bhi nahi hai. FMCG aur health & wellness sector mein competition bohot zyaada hai. HUL aur Marico jaisi established companies ke paas strong distribution network aur brand loyalty hai. Haalanki Wingreens ne positive EBITDA kama liya hai, unko consistent net profit ki taraf jaana hoga. Safe Harvest ko integrate karne mein bhi execution risks hain, jisse growth slow ho sakti hai aur IPO taiyari par asar pad sakta hai. Valuation ko justify karne ke liye unko future mein zabardast growth dikhani padegi.

IPO Ke Liye Kya Hai Aage?

Wingreens ka goal saaf hai - size aur market presence badhana IPO se pehle. Safe Harvest ko successfully integrate karna, growth maintain karna aur net profit kamaana inke liye crucial hoga. Health and wellness sector mein consolidation chal raha hai, toh ho sakta hai Wingreens aur companies kharide ya khud kisi badi company ke target ban jaye. Investors unke financial performance aur strategy par nazar rakhenge.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.